Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 2

Q&A 172: the OVERLORD-MS study

Rituximab vs. Ocrelizumab; which is superior?

Rituximab Noninferior to Ocrelizumab in Relapsing MS

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of a

Second botulism outbreak in seven months linked to Nara Organics baby formula raises questions about FDA oversight and industry safety standards

For the second time in seven months, I am writing about a baby formula that is carrying the toxin that causes botulism.

<![CDATA[Weighing Long-Term Survival and Quality of Life With Atezolizumab Plus Bevacizumab]]>

Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF

Conditions : RSV Immunization; HIV Interventions : Drug: RSVpreF Sponsors : University of British Columbia; Women's Health Research Institut

The Math Behind RSV Protection: What Expanding Infant Coverage Actually Achieves

A new mathematical model shows that expanding RSV antibody prophylaxis to more infants could prevent infections across all age groups—but wo